Search tickers, companies, topics

Universal file

SEC-verified company · Nasdaq · IART

INTEGRA LIFESCIENCES HOLDINGS CORP

CompareShare by email

1 sourced report in this file.

Verified identity

Start with the filing record

The identity and ticker come from the SEC’s official company ticker mapping. Market and editorial coverage are not inferred from that record.

Ticker
IART
SEC company number (CIK)
0000917520
Exchange
Nasdaq
Universe updated
Aug 22, 2026
Open SEC filings

Market price

Market price

Latest quoteOpens Google

Coverage digest

Our reporting on INTEGRA LIFESCIENCES HOLDINGS CORP

TickerGrove has published 1 sourced report on INTEGRA LIFESCIENCES HOLDINGS CORP since Oct 2, 2026. The latest, published Oct 2, 2026, is “Integra cuts 2026 outlook as flood recovery extends into next year”

The medical-device maker lowers sales and adjusted earnings guidance while separately seeking a $600 million refinancing. Preliminary results and financing terms remain unfinished.

The report's verified figures include Integra full-year reported revenue guidance U.S. dollars; management forecast of $1.634 billion–$1.654 billion (Full year 2026; outlook reduced October 2, 2026) and Proposed senior secured Term Loan B U.S. dollars; proposed principal amount of $600 million (Launched October 2, 2026; seven-year proposed tenor; not completed financing).

TickerGrove coverage

Latest on INTEGRA LIFESCIENCES HOLDINGS CORP

Research foundation

Read the filing with the right frame